Inhibition of CaMKII and other strategies targeting specific signaling pathways linking CaMKII to apoptosis may offer therapeutic approaches to a variety of hyperglycemia-induced diseases such as DR. The gene discussed is CAMK2G; the disease is Hyperglycemia.